Peter R Mansfield

Summary

Affiliation: University of Adelaide
Country: Australia

Publications

  1. ncbi request reprint Do advertisements in clinical software influence prescribing?
    Peter R Mansfield
    Discipline of General Practice, University of Adelaide, Adelaide, SA, Australia
    Med J Aust 188:13-4. 2008
  2. ncbi request reprint Banning all drug promotion is the best option pending major reforms
    Peter R Mansfield
    Department of General Practice, University of Adelaide, Australia
    J Bioeth Inq 2:75-81. 2005
  3. ncbi request reprint Management of hyperlipidaemia
    Nigel Stocks
    Department of General Practice, University of Adelaide, South Australia
    Aust Fam Physician 34:447-53. 2005
  4. pmc Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study
    Brett D Montgomery
    Discipline of General Practice, School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Claremont, Western Australia, Australia
    BMC Public Health 8:167. 2008
  5. ncbi request reprint The ethics of pharmaceutical industry relationships with medical students
    Wendy A Rogers
    Department of Medical Education, Flinders University, GPO Box 2100, Adelaide, SA 5001, Australia
    Med J Aust 180:411-4. 2004
  6. ncbi request reprint Is Australia's national medicines policy failing? The case of COX-2 inhibitors
    Agnes Vitry
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia
    Int J Health Serv 37:735-44. 2007
  7. ncbi request reprint Healthy Skepticism's new AdWatch: understanding drug promotion
    Peter R Mansfield
    Healthy Skepticism Inc, Willunga, SA, Australia
    Med J Aust 179:644-5. 2003
  8. ncbi request reprint Bribes for doctors: a gift for bioethicists?
    Peter R Mansfield
    University of Adelaide, Australia
    Am J Bioeth 3:47-8. 2003
  9. ncbi request reprint Direct-to-consumer advertising is more profitable if it is misleading
    Peter R Mansfield
    Director, Healthy Skepticism, Willunga, SA, Australia
    N Z Med J 116:U610. 2003
  10. ncbi request reprint Revealing all
    Michael Sorokin
    Healthy Skepticism Inc, Willunga, SA, Australia
    Lancet Infect Dis 3:270-1. 2003

Detail Information

Publications19

  1. ncbi request reprint Do advertisements in clinical software influence prescribing?
    Peter R Mansfield
    Discipline of General Practice, University of Adelaide, Adelaide, SA, Australia
    Med J Aust 188:13-4. 2008
    ..Pharmaceutical companies must believe there are benefits from advertising, but just what these benefits are, and how they are measured, is not clear...
  2. ncbi request reprint Banning all drug promotion is the best option pending major reforms
    Peter R Mansfield
    Department of General Practice, University of Adelaide, Australia
    J Bioeth Inq 2:75-81. 2005
    ..Consequently, pending major reforms, it is appropriate for governments to restrict drug promotion as much as is politically achievable...
  3. ncbi request reprint Management of hyperlipidaemia
    Nigel Stocks
    Department of General Practice, University of Adelaide, South Australia
    Aust Fam Physician 34:447-53. 2005
    ..In Australia, the use of cholesterol lowering drugs, mainly statins, consumes over 880 million dollars or 16% of the Pharmaceutical Benefits Scheme drug budget and is growing...
  4. pmc Do advertisements for antihypertensive drugs in Australia promote quality prescribing? A cross-sectional study
    Brett D Montgomery
    Discipline of General Practice, School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Claremont, Western Australia, Australia
    BMC Public Health 8:167. 2008
    ..Our study therefore aimed to determine whether print advertisements for antihypertensive medications promote quality prescribing in hypertension...
  5. ncbi request reprint The ethics of pharmaceutical industry relationships with medical students
    Wendy A Rogers
    Department of Medical Education, Flinders University, GPO Box 2100, Adelaide, SA 5001, Australia
    Med J Aust 180:411-4. 2004
    ..Medical educators have a duty of care to protect students from influence by pharmaceutical companies...
  6. ncbi request reprint Is Australia's national medicines policy failing? The case of COX-2 inhibitors
    Agnes Vitry
    Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia
    Int J Health Serv 37:735-44. 2007
    ....
  7. ncbi request reprint Healthy Skepticism's new AdWatch: understanding drug promotion
    Peter R Mansfield
    Healthy Skepticism Inc, Willunga, SA, Australia
    Med J Aust 179:644-5. 2003
    ..asp) aims to improve medical decision-making by illuminating the techniques used in drug advertising. AdWatch draws on 20 years of dialogue about drug promotion plus ideas from many disciplines, especially logic, psychology and marketing...
  8. ncbi request reprint Bribes for doctors: a gift for bioethicists?
    Peter R Mansfield
    University of Adelaide, Australia
    Am J Bioeth 3:47-8. 2003
  9. ncbi request reprint Direct-to-consumer advertising is more profitable if it is misleading
    Peter R Mansfield
    Director, Healthy Skepticism, Willunga, SA, Australia
    N Z Med J 116:U610. 2003
  10. ncbi request reprint Revealing all
    Michael Sorokin
    Healthy Skepticism Inc, Willunga, SA, Australia
    Lancet Infect Dis 3:270-1. 2003
  11. pmc The illusion of invulnerability
    Peter R Mansfield
    BMJ 334:1020. 2007
  12. pmc Doctors as lapdogs to drug firms: Independence may be most cost effective way to improve health care
    Peter R Mansfield
    Healthy Skepticism, 34 Methodist Street, Willunga, SA 5172, Australia
    BMJ 333:1121-2. 2006
  13. pmc Another way to tame the monster
    Peter R Mansfield
    BMJ 333:202. 2006
  14. pmc What are the public health effects of direct-to-consumer drug advertising?
    Elizabeth A Almasi
    Stanford University, Stanford, California, USA
    PLoS Med 3:e145. 2006
    ..Critics argue that the information in the adverts is often biased and misleading, and that DTCA raises prescribing costs without net evidence of health benefits...
  15. pmc Direct to consumer advertising
    Peter R Mansfield
    BMJ 330:5-6. 2005
  16. ncbi request reprint Misleading drug promotion--no sign of improvements
    Peter R Mansfield
    Pharmacoepidemiol Drug Saf 13:797-9. 2004
  17. ncbi request reprint Escitalopram: superior to citalopram or a chiral chimera?
    Staffan Svensson
    Department of Clinical Pharmacology, Sahlgren s University Hospital, Gothenburg, Sweden Healthy Skepticism Inc, Willunga, Australia
    Psychother Psychosom 73:10-6. 2004
    ..The manufacturer claims that escitalopram has more efficacy and a faster onset of effect than citalopram. The purpose of this study was to assess how far these claims are justified...
  18. ncbi request reprint Healthy scepticism
    Peter R Mansfield
    Aust Fam Physician 32:777. 2003
  19. ncbi request reprint Drug advertising in medical journals
    Peter R Mansfield
    Lancet 361:879. 2003